New Zealand Companies Out of the 'Chillybin'
Client Alert | 1 min read | 08.19.15
On August 12, the U.S. in a Federal Register notice confirmed that it "has agreed to waive discriminatory purchasing requirements for eligible products and suppliers of New Zealand beginning on August 12, 2015," due to the WTO's approval of New Zealand as a member of the WTO Agreement on Government Procurement (GPA). Joining the 43-member GPA will provide new access to the U.S. federal marketplace for New Zealand-based companies, including "designated country" status under the Trade Agreements Act, and will open immediate doors to federal government contracting opportunities, including GSA and VA Schedule contracts, that generally limit acquisition to end products that are manufactured or substantially transformed in the U.S. or a "designated country."
Contacts
Insights
Client Alert | 4 min read | 01.07.26
On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026.
Client Alert | 3 min read | 01.07.26
CMMC for AI? Defense Policy Law Imposes AI Security Framework and Requirements on Contractors
Client Alert | 3 min read | 01.07.26
New Year, Same CIPA Uncertainty – When Will the Appellate Courts Enter the Chat?
Client Alert | 11 min read | 01.07.26
